CD44H Regulates Tumor Cell Migration on Hyaluronate-coated Substrate

Overview

Journal J Cell Biol

Specialty Cell Biology

Date 1992 Aug 1

PMID 1380003

Citations 87

Authors

L Thomas

H R Byers

J Vink

I Stamenkovic

Affiliations

Soon will be listed here.

Abstract

CD44 is a broadly distributed cell surface glycoprotein expressed in different isoforms in various tissues and cell lines. One of two recently characterized human isoforms, CD44H, is a cell surface receptor for hyaluronate, suggesting a role in the regulation of cell-cell and cell-substrate interactions as well as of cell migration. While CD44H has been shown to mediate cell adhesion, direct demonstration that CD44H expression promotes cell motility has been lacking. In this work we show that a human melanoma cell line, stably transfected with CD44H, displays enhanced motility on hyaluronate-coated surfaces while transfectants expressing an isoform that does not bind hyaluronate, CD44E, fail to do so. Migration of CD44H-expressing transfectants is observed to be blocked by a soluble CD44-immunoglobulin fusion protein as well as by anti-CD44 antibody, and to depend on the presence of the cytoplasmic domain of CD44. However, cells expressing CD44H cytoplasmic deletion mutants retain significant binding capacity to hyaluronate-coated substrate. Taken together, our results provide direct evidence that CD44H plays a major role in regulating cell migration on hyaluronate-coated substrate.

Citing Articles

CD44 Intracellular Domain: A Long Tale of a Short Tail.

Skandalis S Cancers (Basel). 2023; 15(20).

PMID: 37894408 PMC: 10605500. DOI: 10.3390/cancers15205041.

Circulating Tumor Cells Adhesion: Application in Biosensors.

Paglia E, Baldin E, Freitas G, Santiago T, Neto J, Silva J Biosensors (Basel). 2023; 13(9).

PMID: 37754116 PMC: 10526177. DOI: 10.3390/bios13090882.

To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma.

Poole M, Schwartz R, Lambert W, Alhatem A Arch Dermatol Res. 2022; 315(4):903-915.

PMID: 36394634 DOI: 10.1007/s00403-022-02468-3.

Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease.

Ugwoke C, Cvetko E, Umek N Int J Mol Sci. 2022; 23(19).

PMID: 36233143 PMC: 9569978. DOI: 10.3390/ijms231911843.

Interactions between Nitric Oxide and Hyaluronan Implicate the Migration of Breast Cancer Cells.

Alsharabasy A, Glynn S, Farras P, Pandit A Biomacromolecules. 2022; 23(9):3621-3647.

PMID: 35921128 PMC: 9472231. DOI: 10.1021/acs.biomac.2c00545.

References

Quackenbush E, Vera S, Greaves A, Letarte M . Confirmation by peptide sequence and co-expression on various cell types of the identity of CD44 and P85 glycoprotein. Mol Immunol. 1990; 27(10):947-55. DOI: 10.1016/0161-5890(90)90117-i. View

Watson S, Imai Y, Fennie C, Geoffroy J, Rosen S, Lasky L . A homing receptor-IgG chimera as a probe for adhesive ligands of lymph node high endothelial venules. J Cell Biol. 1990; 110(6):2221-9. PMC: 2116131. DOI: 10.1083/jcb.110.6.2221. View

Lacy B, Underhill C . The hyaluronate receptor is associated with actin filaments. J Cell Biol. 1987; 105(3):1395-404. PMC: 2114800. DOI: 10.1083/jcb.105.3.1395. View

Kalomiris E, Bourguignon L . Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem. 1989; 264(14):8113-9. View

Goodman S, Risse G, von der Mark K . The E8 subfragment of laminin promotes locomotion of myoblasts over extracellular matrix. J Cell Biol. 1989; 109(2):799-809. PMC: 2115702. DOI: 10.1083/jcb.109.2.799. View

Knudson W, Biswas C, Li X, Nemec R, Toole B . The role and regulation of tumour-associated hyaluronan. Ciba Found Symp. 1989; 143:150-9; discussion 159-69, 281-5. DOI: 10.1002/9780470513774.ch10. View

Seed B . An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2. Nature. 1987; 329(6142):840-2. DOI: 10.1038/329840a0. View

Jacobson K, Odell D, Holifield B, MURPHY T, August J . Redistribution of a major cell surface glycoprotein during cell movement. J Cell Biol. 1984; 99(5):1613-23. PMC: 2113370. DOI: 10.1083/jcb.99.5.1613. View

Knudson W, Biswas C, Toole B . Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc Natl Acad Sci U S A. 1984; 81(21):6767-71. PMC: 392012. DOI: 10.1073/pnas.81.21.6767. View

10.

Lindahl U, Hook M . Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem. 1978; 47:385-417. DOI: 10.1146/annurev.bi.47.070178.002125. View

11.

Aruffo A, Stamenkovic I, Melnick M, Underhill C, Seed B . CD44 is the principal cell surface receptor for hyaluronate. Cell. 1990; 61(7):1303-13. DOI: 10.1016/0092-8674(90)90694-a. View

12.

Webb D, Shimizu Y, van Seventer G, Shaw S, Gerrard T . LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science. 1990; 249(4974):1295-7. DOI: 10.1126/science.1697984. View

13.

Turley E, Austen L, Vandeligt K, Clary C . Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol. 1991; 112(5):1041-7. PMC: 2288867. DOI: 10.1083/jcb.112.5.1041. View

14.

Hofmann M, Rudy W, Zoller M, Tolg C, Ponta H, Herrlich P . CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. Cancer Res. 1991; 51(19):5292-7. View

15.

Lesley J, He Q, Miyake K, Hamann A, HYMAN R, Kincade P . Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody. J Exp Med. 1992; 175(1):257-66. PMC: 2119065. DOI: 10.1084/jem.175.1.257. View

16.

Byers H, Etoh T, Doherty J, Sober A, Mihm Jr M . Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma. Time-lapse and image analysis. Am J Pathol. 1991; 139(2):423-35. PMC: 1886079. View

17.

Sy M, Guo Y, Stamenkovic I . Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med. 1991; 174(4):859-66. PMC: 2118964. DOI: 10.1084/jem.174.4.859. View

18.

Denning S, Le P, Singer K, Haynes B . Antibodies against the CD44 p80, lymphocyte homing receptor molecule augment human peripheral blood T cell activation. J Immunol. 1990; 144(1):7-15. View

19.

Horst E, Meijer C, Radaszkiewicz T, Ossekoppele G, van Krieken J, Pals S . Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Leukemia. 1990; 4(8):595-9. View

20.

Ruoslahti E, Yamaguchi Y . Proteoglycans as modulators of growth factor activities. Cell. 1991; 64(5):867-9. DOI: 10.1016/0092-8674(91)90308-l. View